Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

There is high-certainty evidence that incentives improve smoking cessation rates at long-term follow-up across populations.

Individuals with cutaneous lupus erythematosus have an increased ASCVD risk when compared with those without cutaneous lupus erythematosus.

According to a recent study, there have been shifts in both the patterns and correlates of ketamine use from 2015 to 2022.

The US FDA has amended its color additive regulations to no longer allow the use of FD&C Act Red No. 3 in food and ingested drugs.

Sex-related differences in pulmonary complications were found among men vs women with SSc, specifically in the prevalence of ILD and SAD.

US FDA officials have uncovered dozens of violations at a McDonald's supplier tied to last year's deadly E.coli outbreak.

A new database, GroceryDB, can show the degree of processing of more than 50,000 food items sold at Walmart, Target, and Whole Foods.

Fifteen candidate genetic variants account for only 0.40 percent of variation in opioid use disorder (OUD) risk, according to a study published online Jan. 9 in ...

After adjusting for demographics, no significant difference in cancer risk was observed for patients with vitiligo and patients without vitiligo.

Race and appointment availability are significant predictors for the continuity of care among patients with chronic inflammatory skin disease.

Historical redlining is linked to care utilization and fragmentation among patients with rheumatic conditions, highlighting the role of structural racism in these disparities.